Literature DB >> 20659107

Biomarkers and endogenous determinants of dofetilide-induced torsades de pointes in α(1) -adrenoceptor-stimulated, anaesthetized rabbits.

Attila S Farkas1, László Rudas, Péter Makra, Norbert Csík, István Leprán, Tamás Forster, Miklós Csanády, Julius Gy Papp, András Varró, András Farkas.   

Abstract

BACKGROUND AND
PURPOSE: Torsades de pointes (TdP) liability is a stochastic event, which indicates that unidentified factors have an important role in facilitating the initiation of TdP by increasing the probability of TdP occurrence. We sought to identify factors that facilitate drug-induced TdP. EXPERIMENTAL APPROACH: We studied dofetilide-induced TdP in pentobarbital-anaesthetized, phenylephrine-sensitized rabbits, seeking biomarkers that discriminated between the animals that experienced TdP ('TdP+' animals) and those that did not ('TdP-' animals). As novel variables, the beat-to-beat variability and instability of ECG intervals were measured at preset times, irrespective of whether or not hearts were in stable sinus rhythm ('absolute' variability and instability). Autonomic activity was also determined. KEY
RESULTS: Dofetilide delayed repolarization and induced arrhythmias prior to TdP. The variability of the coupling interval and shape of arrhythmic beats before TdP were significantly greater in the 'TdP+' group than in the 'TdP-' group. Accordingly, the 'absolute' variability and instability of the ECG intervals were significantly elevated in the 'TdP+' group. Phenylephrine increased significantly the up-baroreflex sensitivity in the 'TdP+' group before dofetilide administration. CONCLUSIONS AND IMPLICATIONS: 'Preceding' arrhythmias have characteristics that permit prediction of TdP occurrence: the more chaotic the ventricular rhythm, the greater the probability of TdP initiation. This suggests that complexity of the arrhythmic beats may play an important mechanistic role in TdP genesis. The electrical instability quantified by the novel 'absolute' variability and instability parameters correlates with the probability of TdP occurrence. Baroreflex may contribute to TdP genesis in vivo.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20659107      PMCID: PMC3010562          DOI: 10.1111/j.1476-5381.2010.00965.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  35 in total

1.  How to measure electrocardiographic QT interval in the anaesthetized rabbit.

Authors:  András Farkas; Andrew J Batey; Susan J Coker
Journal:  J Pharmacol Toxicol Methods       Date:  2004 Nov-Dec       Impact factor: 1.950

Review 2.  Refining detection of drug-induced proarrhythmia: QT interval and TRIaD.

Authors:  Rashmi R Shah; Luc M Hondeghem
Journal:  Heart Rhythm       Date:  2005-07       Impact factor: 6.343

3.  Antiarrhythmic effects of potassium channel openers in rhythm abnormalities related to delayed repolarization.

Authors:  L Carlsson; C Abrahamsson; L Drews; G Duker
Journal:  Circulation       Date:  1992-04       Impact factor: 29.690

4.  A new method to calculate the beat-to-beat instability of QT duration in drug-induced long QT in anesthetized dogs.

Authors:  H van der Linde; A Van de Water; W Loots; B Van Deuren; H R Lu; K Van Ammel; M Peeters; D J Gallacher
Journal:  J Pharmacol Toxicol Methods       Date:  2005 Jul-Aug       Impact factor: 1.950

5.  QTU-prolongation and torsades de pointes induced by putative class III antiarrhythmic agents in the rabbit: etiology and interventions.

Authors:  L Carlsson; O Almgren; G Duker
Journal:  J Cardiovasc Pharmacol       Date:  1990-08       Impact factor: 3.105

6.  Importance of extracardiac alpha1-adrenoceptor stimulation in assisting dofetilide to induce torsade de pointes in rabbit hearts.

Authors:  Attila S Farkas; Károly Acsai; András Tóth; László Dézsi; Szabolcs Orosz; Tamás Forster; Miklós Csanády; Julius Gy Papp; András Varró; András Farkas
Journal:  Eur J Pharmacol       Date:  2006-03-20       Impact factor: 4.432

7.  Comparative assessment of ibutilide, D-sotalol, clofilium, E-4031, and UK-68,798 in a rabbit model of proarrhythmia.

Authors:  L V Buchanan; G Kabell; M N Brunden; J K Gibson
Journal:  J Cardiovasc Pharmacol       Date:  1993-10       Impact factor: 3.105

8.  Modulated dispersion explains changes in arrhythmia vulnerability during premature stimulation of the heart.

Authors:  K R Laurita; S D Girouard; F G Akar; D S Rosenbaum
Journal:  Circulation       Date:  1998-12-15       Impact factor: 29.690

9.  Comparison of the antiarrhythmic and the proarrhythmic effect of almokalant in anaesthetised rabbits.

Authors:  A Farkas; I Leprán; J G Papp
Journal:  Eur J Pharmacol       Date:  1998-04-10       Impact factor: 4.432

10.  Spontaneous sequences of onset of torsade de pointes in patients with acquired prolonged repolarization: quantitative analysis of Holter recordings.

Authors:  E H Locati; P Maison-Blanche; P Dejode; B Cauchemez; P Coumel
Journal:  J Am Coll Cardiol       Date:  1995-06       Impact factor: 24.094

View more
  4 in total

1.  Absolute beat-to-beat variability and instability parameters of ECG intervals: biomarkers for predicting ischaemia-induced ventricular fibrillation.

Authors:  Annamária Sarusi; Ferenc Rárosi; Mónika Szűcs; Norbert Csík; Attila S Farkas; Julius Gy Papp; András Varró; Tamás Forster; Michael J Curtis; András Farkas
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 2.  Cardiac ventricular repolarization reserve: a principle for understanding drug-related proarrhythmic risk.

Authors:  András Varró; István Baczkó
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

3.  The high frequency relationship: implications for torsadogenic hERG blockers.

Authors:  P Champeroux; J Y Le Guennec; S Jude; C Laigot; A Maurin; M L Sola; J S L Fowler; S Richard; J Thireau
Journal:  Br J Pharmacol       Date:  2016-01-14       Impact factor: 8.739

4.  An increasing electromechanical window is a predictive marker of ventricular fibrillation in anesthetized rabbit with ischemic heart.

Authors:  Vudhiporn Limprasutr; Prapawadee Pirintr; Anusak Kijtawornrat; Robert L Hamlin
Journal:  Exp Anim       Date:  2017-11-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.